{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T05:13:58Z","timestamp":1775625238470,"version":"3.50.1"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,12,15]]},"DOI":"10.1093\/hmg\/ddi413","type":"journal-article","created":{"date-parts":[[2005,11,9]],"date-time":"2005-11-09T02:48:13Z","timestamp":1131504493000},"page":"3885-3897","source":"Crossref","is-referenced-by-count":180,"title":["Stress-induced alterations in parkin solubility promote parkin aggregation and compromise parkin's protective function"],"prefix":"10.1093","volume":"14","author":[{"given":"Cheng","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han Seok","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bobby","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fai","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine C.M.","family":"Chew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiam-Peng","family":"Tay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle W.L.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tit-Meng","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuck-Wah","family":"Soong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Pletnikova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Troncoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valina L.","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ted M.","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kah-Leong","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2005,11,8]]},"reference":[{"key":"key\n\t\t\t\t20171011143751_DDI413C1","doi-asserted-by":"crossref","unstructured":"Dawson, T.M. and Dawson, V.L. ( 2003 ) Molecular pathways of neurodegeneration in Parkinson's disease. Science , 302 , 819 \u2013822.","DOI":"10.1126\/science.1087753"},{"key":"key\n\t\t\t\t20171011143751_DDI413C2","doi-asserted-by":"crossref","unstructured":"Lim, K.L., Dawson, V.L. and Dawson, T.M. ( 2003 ) The cast of molecular characters in Parkinson's disease: felons, conspirators, and suspects. Ann. NY Acad. Sci. , 991 , 80 \u201392.","DOI":"10.1111\/j.1749-6632.2003.tb07465.x"},{"key":"key\n\t\t\t\t20171011143751_DDI413C3","doi-asserted-by":"crossref","unstructured":"Moore, D.J., West, A.B., Dawson, V.L. and Dawson, T.M. ( 2005 ) Molecular pathophysiology of Parkinson's disease. Annu. Rev. Neurosci. , 28 , 55 \u201384.","DOI":"10.1146\/annurev.neuro.28.061604.135718"},{"key":"key\n\t\t\t\t20171011143751_DDI413C4","doi-asserted-by":"crossref","unstructured":"Imai, Y. and Takahashi, R. ( 2004 ) How do parkin mutations result in neurodegeneration? Curr. Opin. Neurobiol. , 14 , 384 \u2013389.","DOI":"10.1016\/j.conb.2004.04.002"},{"key":"key\n\t\t\t\t20171011143751_DDI413C5","doi-asserted-by":"crossref","unstructured":"Mata, I.F., Lockhart, P.J. and Farrer, M.J. ( 2004 ) Parkin genetics: one model for Parkinson's disease. Hum. Mol. Genet. , 13 , R127 \u2013R133.","DOI":"10.1093\/hmg\/ddh089"},{"key":"key\n\t\t\t\t20171011143751_DDI413C6","doi-asserted-by":"crossref","unstructured":"Foroud, T., Uniacke, S.K., Liu, L., Pankratz, N., Rudolph, A., Halter, C., Shults, C., Marder, K., Conneally, P.M. and Nichols, W.C. ( 2003 ) Heterozygosity for a mutation in the parkin gene leads to later onset Parkinson disease. Neurology , 60 , 796 \u2013801.","DOI":"10.1212\/01.WNL.0000049470.00180.07"},{"key":"key\n\t\t\t\t20171011143751_DDI413C7","doi-asserted-by":"crossref","unstructured":"Kann, M., Jacobs, H., Mohrmann, K., Schumacher, K., Hedrich, K., Garrels, J., Wiegers, K., Schwinger, E., Pramstaller, P.P., Breakefield, X.O. et\u00a0al. ( 2002 ) Role of parkin mutations in 111 community-based patients with early-onset Parkinsonism. Ann. Neurol. , 51 , 621 \u2013625.","DOI":"10.1002\/ana.10179"},{"key":"key\n\t\t\t\t20171011143751_DDI413C8","doi-asserted-by":"crossref","unstructured":"West, A.B., Maraganore, D., Crook, J., Lesnick, T., Lockhart, P.J., Wilkes, K.M., Kapatos, G., Hardy, J.A. and Farrer, M.J. ( 2002 ) Functional association of the parkin gene promoter with idiopathic Parkinson's disease. Hum. Mol. Genet. , 11 , 2787 \u20132792.","DOI":"10.1093\/hmg\/11.22.2787"},{"key":"key\n\t\t\t\t20171011143751_DDI413C9","doi-asserted-by":"crossref","unstructured":"Feany, M.B. and Pallanck, L.J. ( 2003 ) Parkin: a multipurpose neuroprotective agent? Neuron , 38 , 13 \u201316.","DOI":"10.1016\/S0896-6273(03)00201-0"},{"key":"key\n\t\t\t\t20171011143751_DDI413C10","doi-asserted-by":"crossref","unstructured":"Higashi, Y., Asanuma, M., Miyazaki, I., Hattori, N., Mizuno, Y. and Ogawa, N. ( 2004 ) Parkin attenuates manganese-induced dopaminergic cell death. J. Neurochem. , 89 , 1490 \u20131497.","DOI":"10.1111\/j.1471-4159.2004.02445.x"},{"key":"key\n\t\t\t\t20171011143751_DDI413C11","doi-asserted-by":"crossref","unstructured":"Petrucelli, L., O'Farrell, C., Lockhart, P.J., Baptista, M., Kehoe, K., Vink, L., Choi, P., Wolozin, B., Farrer, M., Hardy, J. et\u00a0al. ( 2002 ) Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons. Neuron , 36 , 1007 \u20131019.","DOI":"10.1016\/S0896-6273(02)01125-X"},{"key":"key\n\t\t\t\t20171011143751_DDI413C12","doi-asserted-by":"crossref","unstructured":"Tsai, Y.C., Fishman, P.S., Thakor, N.V. and Oyler, G.A. ( 2003 ) Parkin facilitates the elimination of expanded polyglutamine proteins and leads to preservation of proteasome function. J. Biol. Chem. , 278 , 22044 \u201322055.","DOI":"10.1074\/jbc.M212235200"},{"key":"key\n\t\t\t\t20171011143751_DDI413C13","doi-asserted-by":"crossref","unstructured":"Yang, Y., Nishimura, I., Imai, Y., Takahashi, R. and Lu, B. ( 2003 ) Parkin suppresses dopaminergic neuron-selective neurotoxicity induced by Pael-R in Drosophila . Neuron , 37 , 911 \u2013924.","DOI":"10.1016\/S0896-6273(03)00143-0"},{"key":"key\n\t\t\t\t20171011143751_DDI413C14","doi-asserted-by":"crossref","unstructured":"Ko, H.S., von Coelln, R., Sriram, S.R., Kim, S.W., Chung, K.K., Pletnikova, O., Troncoso, J., Johnson, B., Saffary, R., Goh, E.L. et\u00a0al. ( 2005 ) Accumulation of the authentic parkin substrate aminoacyl-tRNA synthetase cofactor, p38\/JTV-1, leads to catecholaminergic cell death. J. Neurosci. , 25 , 7968 \u20137978.","DOI":"10.1523\/JNEUROSCI.2172-05.2005"},{"key":"key\n\t\t\t\t20171011143751_DDI413C15","doi-asserted-by":"crossref","unstructured":"Staropoli, J.F., McDermott, C., Martinat, C., Schulman, B., Demireva, E. and Abeliovich, A. ( 2003 ) Parkin is a component of an SCF-like ubiquitin ligase complex and protects postmitotic neurons from kainate excitotoxicity. Neuron , 37 , 735 \u2013749.","DOI":"10.1016\/S0896-6273(03)00084-9"},{"key":"key\n\t\t\t\t20171011143751_DDI413C16","doi-asserted-by":"crossref","unstructured":"Darios, F., Corti, O., Lucking, C.B., Hampe, C., Muriel, M.P., Abbas, N., Gu, W.J., Hirsch, E.C., Rooney, T., Ruberg, M. et\u00a0al. ( 2003 ) Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death. Hum. Mol. Genet. , 12 , 517 \u2013526.","DOI":"10.1093\/hmg\/ddg044"},{"key":"key\n\t\t\t\t20171011143751_DDI413C17","doi-asserted-by":"crossref","unstructured":"Jiang, H., Ren, Y., Zhao, J. and Feng, J. ( 2004 ) Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis. Hum. Mol. Genet. , 13 , 1745 \u20131754.","DOI":"10.1093\/hmg\/ddh180"},{"key":"key\n\t\t\t\t20171011143751_DDI413C18","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Gao, J., Chung, K.K., Huang, H., Dawson, V.L. and Dawson, T.M. ( 2000 ) Parkin functions as an E2-dependent ubiquitin-protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. Proc. Natl Acad. Sci. USA , 97 , 13354 \u201313359.","DOI":"10.1073\/pnas.240347797"},{"key":"key\n\t\t\t\t20171011143751_DDI413C19","doi-asserted-by":"crossref","unstructured":"Chung, K.K., Zhang, Y., Lim, K.L., Tanaka, Y., Huang, H., Gao, J., Ross, C.A., Dawson, V.L. and Dawson, T.M. ( 2001 ) Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease. Nat. Med. , 7 , 1144 \u20131150.","DOI":"10.1038\/nm1001-1144"},{"key":"key\n\t\t\t\t20171011143751_DDI413C20","doi-asserted-by":"crossref","unstructured":"Kalia, S.K., Lee, S., Smith, P.D., Liu, L., Crocker, S.J., Thorarinsdottir, T.E., Glover, J.R., Fon, E.A., Park, D.S. and Lozano, A.M. ( 2004 ) BAG5 inhibits parkin and enhances dopaminergic neuron degeneration. Neuron , 44 , 931 \u2013945.","DOI":"10.1016\/j.neuron.2004.11.026"},{"key":"key\n\t\t\t\t20171011143751_DDI413C21","doi-asserted-by":"crossref","unstructured":"Yamada, M., Mizuno, Y. and Mochizuki, H. ( 2005 ) Parkin gene therapy for alpha-synucleinopathy: a rat model of Parkinson's disease. Hum. Gene Ther. , 16 , 262 \u2013270.","DOI":"10.1089\/hum.2005.16.262"},{"key":"key\n\t\t\t\t20171011143751_DDI413C22","doi-asserted-by":"crossref","unstructured":"Lo Bianco, C., Schneider, B.L., Bauer, M., Sajadi, A., Brice, A., Iwatsubo, T. and Aebischer, P. ( 2004 ) Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson's disease. Proc. Natl Acad. Sci. USA , 101 , 17510 \u201317515.","DOI":"10.1073\/pnas.0405313101"},{"key":"key\n\t\t\t\t20171011143751_DDI413C23","doi-asserted-by":"crossref","unstructured":"Pawlyk, A.C., Giasson, B.I., Sampathu, D.M., Perez, F.A., Lim, K.L., Dawson, V.L., Dawson, T.M., Palmiter, R.D., Trojanowski, J.Q. and Lee, V.M. ( 2003 ) Novel monoclonal antibodies demonstrate biochemical variation of brain parkin with age. J. Biol. Chem. , 278 , 48120 \u201348128.","DOI":"10.1074\/jbc.M306889200"},{"key":"key\n\t\t\t\t20171011143751_DDI413C24","doi-asserted-by":"crossref","unstructured":"Wang, C., Tan, J.M., Ho, M.W., Zaiden, N., Wong, S.H., Chew, C.L., Eng, P.W., Lim, T.M., Dawson, T.M. and Lim, K.L. ( 2005 ) Alterations in the solubility and intracellular localization of parkin by several familial Parkinson's disease-linked point mutations. J. Neurochem. , 93 , 422 \u2013431.","DOI":"10.1111\/j.1471-4159.2005.03023.x"},{"key":"key\n\t\t\t\t20171011143751_DDI413C25","doi-asserted-by":"crossref","unstructured":"Sriram, S.R., Li, X., Ko, H.S., Chung, K.K., Wong, E., Lim, K.L., Dawson, V.L. and Dawson, T.M. ( 2005 ) Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin. Hum. Mol. Genet. , 14 , 2571 \u20132586.","DOI":"10.1093\/hmg\/ddi292"},{"key":"key\n\t\t\t\t20171011143751_DDI413C26","doi-asserted-by":"crossref","unstructured":"Winklhofer, K.F., Henn, I.H., Kay-Jackson, P.C., Heller, U. and Tatzelt, J. ( 2003 ) Inactivation of parkin by oxidative stress and C-terminal truncations: a protective role of molecular chaperones. J. Biol. Chem. , 278 , 47199 \u201347208.","DOI":"10.1074\/jbc.M306769200"},{"key":"key\n\t\t\t\t20171011143751_DDI413C27","doi-asserted-by":"crossref","unstructured":"Chung, K.K., Thomas, B., Li, X., Pletnikova, O., Troncoso, J.C., Marsh, L., Dawson, V.L. and Dawson, T.M. ( 2004 ) S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function. Science , 304 , 1328 \u20131331.","DOI":"10.1126\/science.1093891"},{"key":"key\n\t\t\t\t20171011143751_DDI413C28","doi-asserted-by":"crossref","unstructured":"Lotharius, J. and Brundin, P. ( 2002 ) Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein. Nat. Rev. Neurosci. , 3 , 932 \u2013942.","DOI":"10.1038\/nrn983"},{"key":"key\n\t\t\t\t20171011143751_DDI413C29","doi-asserted-by":"crossref","unstructured":"Tsirigotis, M., Zhang, M., Chiu, R.K., Wouters, B.G. and Gray, D.A. ( 2001 ) Sensitivity of mammalian cells expressing mutant ubiquitin to protein-damaging agents. J. Biol. Chem. , 276 , 46073 \u201346078.","DOI":"10.1074\/jbc.M109023200"},{"key":"key\n\t\t\t\t20171011143751_DDI413C30","unstructured":"Lim, K.L., Dawson, V.L. and Dawson, T.M. ( 2005 ) Parkin-mediated lysine 63-linked polyubiquitination\u2014a link to Lewy body formation? Neurobiol. Aging , Epub ahead of print October 5, 2005."},{"key":"key\n\t\t\t\t20171011143751_DDI413C31","doi-asserted-by":"crossref","unstructured":"Di Monte, D.A., Lavasani, M. and Manning-Bog, A.B. ( 2002 ) Environmental factors in Parkinson's disease. Neurotoxicology , 23 , 487 \u2013502.","DOI":"10.1016\/S0161-813X(02)00099-2"},{"key":"key\n\t\t\t\t20171011143751_DDI413C32","doi-asserted-by":"crossref","unstructured":"Ostrerova-Golts, N., Petrucelli, L., Hardy, J., Lee, J.M., Farer, M. and Wolozin, B. ( 2000 ) The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity. J. Neurosci. , 20 , 6048 \u20136054.","DOI":"10.1523\/JNEUROSCI.20-16-06048.2000"},{"key":"key\n\t\t\t\t20171011143751_DDI413C33","doi-asserted-by":"crossref","unstructured":"Paxinou, E., Chen, Q., Weisse, M., Giasson, B.I., Norris, E.H., Rueter, S.M., Trojanowski, J.Q., Lee, V.M. and Ischiropoulos, H. ( 2001 ) Induction of alpha-synuclein aggregation by intracellular nitrative insult. J. Neurosci. , 21 , 8053 \u20138061.","DOI":"10.1523\/JNEUROSCI.21-20-08053.2001"},{"key":"key\n\t\t\t\t20171011143751_DDI413C34","doi-asserted-by":"crossref","unstructured":"Sherer, T.B., Betarbet, R., Stout, A.K., Lund, S., Baptista, M., Panov, A.V., Cookson, M.R. and Greenamyre, J.T. ( 2002 ) An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage. J. Neurosci. , 22 , 7006 \u20137015.","DOI":"10.1523\/JNEUROSCI.22-16-07006.2002"},{"key":"key\n\t\t\t\t20171011143751_DDI413C35","doi-asserted-by":"crossref","unstructured":"Imai, Y., Soda, M. and Takahashi, R. ( 2000 ) Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity. J. Biol. Chem. , 275 , 35661 \u201335664.","DOI":"10.1074\/jbc.C000447200"},{"key":"key\n\t\t\t\t20171011143751_DDI413C36","doi-asserted-by":"crossref","unstructured":"McNaught, K.S., Belizaire, R., Isacson, O., Jenner, P. and Olanow, C.W. ( 2003 ) Altered proteasomal function in sporadic Parkinson's disease. Exp. Neurol. , 179 , 38 \u201346.","DOI":"10.1006\/exnr.2002.8050"},{"key":"key\n\t\t\t\t20171011143751_DDI413C37","doi-asserted-by":"crossref","unstructured":"Doss-Pepe, E.W., Chen, L. and Madura, K. ( 2005 ) Alpha-synuclein and parkin contribute to the assembly of ubiquitin lysine 63-linked multiubiquitin chains. J. Biol. Chem. , 280 , 16619 \u201316624.","DOI":"10.1074\/jbc.M413591200"},{"key":"key\n\t\t\t\t20171011143751_DDI413C38","doi-asserted-by":"crossref","unstructured":"Lim, K.L., Chew, K.C., Tan, J.M., Wang, C., Chung, K.K., Zhang, Y., Tanaka, Y., Smith, W., Engelender, S., Ross, C.A. et\u00a0al. ( 2005 ) Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formation. J. Neurosci. , 25 , 2002 \u20132009.","DOI":"10.1523\/JNEUROSCI.4474-04.2005"},{"key":"key\n\t\t\t\t20171011143751_DDI413C39","doi-asserted-by":"crossref","unstructured":"Jenner, P. ( 2003 ) Oxidative stress in Parkinson's disease. Ann. Neurol. , 53 (Suppl. 3), S26 \u2013S36; discussion S36\u2013S28.","DOI":"10.1002\/ana.10483"},{"key":"key\n\t\t\t\t20171011143751_DDI413C40","doi-asserted-by":"crossref","unstructured":"Tonks, N.K. ( 2005 ) Redox redux: revisiting PTPs and the control of cell signaling. Cell , 121 , 667 \u2013670.","DOI":"10.1016\/j.cell.2005.05.016"},{"key":"key\n\t\t\t\t20171011143751_DDI413C41","doi-asserted-by":"crossref","unstructured":"Cookson, M.R., Lockhart, P.J., McLendon, C., O'Farrell, C., Schlossmacher, M. and Farrer, M.J. ( 2003 ) RING finger 1 mutations in Parkin produce altered localization of the protein. Hum. Mol. Genet. , 12 , 2957 \u20132965.","DOI":"10.1093\/hmg\/ddg328"},{"key":"key\n\t\t\t\t20171011143751_DDI413C42","doi-asserted-by":"crossref","unstructured":"Gu, W.J., Corti, O., Araujo, F., Hampe, C., Jacquier, S., Lucking, C.B., Abbas, N., Duyckaerts, C., Rooney, T., Pradier, L. et\u00a0al. ( 2003 ) The C289G and C418R missense mutations cause rapid sequestration of human Parkin into insoluble aggregates. Neurobiol. Dis. , 14 , 357 \u2013364.","DOI":"10.1016\/j.nbd.2003.08.011"},{"key":"key\n\t\t\t\t20171011143751_DDI413C43","doi-asserted-by":"crossref","unstructured":"Sriram, S.R., Li, X., Ko, H.S., Chung, K.K., Wong, E., Lim, K.L., Dawson, V.L. and Dawson, T.M. ( 2005 ) Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of Parkin. Hum. Mol. Genet. , 14 , 2571 \u20132586.","DOI":"10.1093\/hmg\/ddi292"},{"key":"key\n\t\t\t\t20171011143751_DDI413C44","doi-asserted-by":"crossref","unstructured":"Yao, D., Gu, Z., Nakamura, T., Shi, Z.Q., Ma, Y., Gaston, B., Palmer, L.A., Rockenstein, E.M., Zhang, Z., Masliah, E. et\u00a0al. ( 2004 ) Nitrosative stress linked to sporadic Parkinson's disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity. Proc. Natl Acad. Sci. USA , 101 , 10810 \u201310814.","DOI":"10.1073\/pnas.0404161101"}],"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/hmg\/article-pdf\/14\/24\/3885\/17242141\/ddi413.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T18:58:04Z","timestamp":1586545084000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/hmg\/article\/14\/24\/3885\/2355857\/Stressinduced-alterations-in-parkin-solubility"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,8]]},"references-count":44,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2005,11,8]]},"published-print":{"date-parts":[[2005,12,15]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/ddi413","relation":{},"ISSN":["1460-2083","0964-6906"],"issn-type":[{"value":"1460-2083","type":"electronic"},{"value":"0964-6906","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,12,15]]},"published":{"date-parts":[[2005,11,8]]}}}